Short-term effects of low-dose estradiol on endothelial function and blood viscosity in nondiabetic postmenopausal overweight women: a double-blind, placebo-controlled study

被引:8
作者
Panazzolo, Diogo G. [1 ,2 ]
da Silva, Lucia H. A. [1 ]
Maranhao, Priscila A. [1 ]
Souza, Maria G. C. [1 ]
Nogueira Neto, Jose F. [3 ]
Leao, Lenora M. C. S. M. [4 ]
Bouskela, Eliete [1 ]
Kraemer-Aguiar, Luiz G. [1 ,4 ]
机构
[1] Univ Estado Rio De Janeiro, Biomed Ctr, Clin & Expt Res Lab Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil
[2] Univ Fed Santa Maria, Univ Hosp Santa Maria, Div Endocrinol, Santa Maria, RS, Brazil
[3] Univ Estado Rio De Janeiro, Lipids Lab LabLip, Policlin Piquet Carneiro, Rio De Janeiro, RJ, Brazil
[4] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Obes Unit,Policlin Piquet Carneiro,Div Endocrinol, Rio De Janeiro, RJ, Brazil
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2016年 / 23卷 / 10期
关键词
Endothelium; Estrogen; Menopause; Microcirculation; Obesity; HORMONE REPLACEMENT THERAPY; ESTROGEN REPLACEMENT; ADHESION MOLECULES; PREVENTION; GLUCOSE; ATHEROSCLEROSIS; METABOLISM; MENOPAUSAL; INSULIN;
D O I
10.1097/GME.0000000000000686
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective:The beneficial effects of estrogen on endothelial function depend on its integrity. This study evaluates the short-term effects of low-dose transdermal estradiol on endothelial function, insulin sensitivity, and blood viscosity in nondiabetic overweight/obese women.Methods:Forty-four nondiabetic overweight/obese women with a history of recent menopause were randomly allocated, in a double-blind fashion, to receive transdermal estradiol (1mg/d, n=22) or placebo (n=22). The following parameters were assessed: endothelial reactivity (venous occlusion plethysmography and nailfold videocapillaroscopy), plasma levels of soluble adhesion molecules, insulin sensitivity (homeostasis model assessment of insulin resistance and areas under the curve of insulin and glucose during an oral glucose tolerance test), and blood and plasma viscosity. Data were expressed as meansSD or medians [first to third quartiles].Results:Participants were aged 51.8 +/- 2.3 years with a body mass index of 31.5 +/- 2.5kg/m(2) and time since menopause was 3 [2-5] years. At baseline, no differences between the groups were observed; however, after 3 months of treatment, the following changes were observed in the estradiol group compared with the placebo group: a decrease in the forearm vascular resistance at baseline (36.37 [24.9-51.27] vs 51.3 [40.88-70.03]mm Hg/mL per min 100mL tissue(-1), P<0.01) and during the postocclusive reactive hyperemia response (15.93 [11.32-22.29] vs 22.13 [16.46-29.7]mm Hg/mL per min 100mL tissue(-1), P<0.01), and an increase in red blood cell velocity at rest (0.316 [0.309-0.326] vs 0.303 [0.293-0.308]mm/s, P<0.001) and during postocclusive reactive hyperemia response (0.374 [0.353-0.376] vs 0.341 [0.333-0.355] mm/s, P<0.001). Furthermore, blood viscosity was lower in the estradiol group than in the placebo group (3.57 +/- 0.12 vs 3.76 +/- 0.22 mPa.s; P<0.01).Conclusions:Short-term use of low-dose transdermal estradiol in nondiabetic overweight/obese women with a history of recent menopause improved endothelial function and decreased blood viscosity compared with placebo.
引用
收藏
页码:1114 / 1121
页数:8
相关论文
共 28 条
  • [1] Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc14-S081, 10.2337/dc13-S011]
  • [2] Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels
    Belfiore, F
    Iannello, S
    Volpicelli, G
    [J]. MOLECULAR GENETICS AND METABOLISM, 1998, 63 (02) : 134 - 141
  • [3] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [4] Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion
    Cucinelli, F
    Paparella, P
    Soranna, L
    Barini, A
    Cinque, B
    Mancuso, S
    Lanzone, A
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (03) : 215 - 223
  • [5] Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance
    De Acular, LGK
    Bahia, LR
    Villela, N
    Laflor, C
    Sicuro, F
    Wiernsperger, N
    Bottino, D
    Bouskela, E
    [J]. DIABETES CARE, 2006, 29 (05) : 1083 - 1089
  • [6] De Franciscis P, 2013, CLIN EXP OBSTET GYN, V40, P233
  • [7] Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease
    Duvernoy, C
    Martin, J
    Briesmiester, K
    Bargardi, A
    Muzik, O
    Mosca, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2783 - 2788
  • [8] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [9] Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study - A randomized, double-blind, placebo-controlled trial
    Kanaya, AM
    Herrington, D
    Vittinghoff, E
    Lin, F
    Grady, D
    Bittner, V
    Cauley, JA
    Barrett-Connor, E
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) : 1 - 9
  • [10] Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women
    Koh, KK
    Ahn, JY
    Jin, DK
    Yoon, BK
    Kim, HS
    Kim, DS
    Shin, MS
    Son, JW
    Choi, IS
    Shin, EK
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (09) : 1459 - 1464